Star Combo Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of S66?
Owner Type	Number of Shares	Ownership Percentage
General Public	9,045,058	6.7%
Public Companies	11,000,000	8.14%
Individual Insiders	57,237,306	42.4%
Private Companies	57,800,537	42.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 18 shareholders own 93.3% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
36.3%	Goldenstar Pharmaceutical Investment Limited	49,000,000	AU$6.9m	0%	no data
28.3%	JinXing Zhang	38,165,510	AU$5.3m	0%	no data
8.48%	Su Zhang	11,448,980	AU$1.6m	0%	no data
8.14%	Lepu Medical Technology (Beijing) Co., Ltd.	11,000,000	AU$1.5m	0%	no data
2.62%	Certane Group Pty Ltd	3,541,178	AU$495.8k	0%	no data
2.54%	Dw & Rl Pty Ltd	3,434,269	AU$480.8k	0%	no data
1.66%	Liang Zuo	2,243,512	AU$314.1k	0%	no data
1.39%	Jixiang Shi	1,880,000	AU$263.2k	8.67%	no data
0.89%	Icomoon Pty Ltd	1,202,090	AU$168.3k	1.69%	no data
0.46%	Eureka Technology Innovation & Investment Pty Ltd	623,000	AU$87.2k	0%	no data
0.38%	Brian Donnelly	507,658	AU$71.1k	5.53%	no data
0.37%	Nguyen Thi	500,000	AU$70.0k	0%	no data
0.36%	Cong Ye Yun	490,000	AU$68.6k	-36.7%	no data
0.35%	Steve Hou	472,238	AU$66.1k	0%	no data
0.34%	Lisha Huang	455,000	AU$63.7k	0%	no data
0.28%	Huilin Lu	381,681	AU$53.4k	0%	no data
0.26%	KangJin Xing	349,000	AU$48.9k	0%	no data
0.25%	Pisan Chowvalit	343,727	AU$48.1k	-0.08%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 13:29
End of Day Share Price	2024/12/13 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Star Combo Pharma Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution